Passifs Courants Changement Date
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 813K 108K 2025-12
Almirall EUR 350.64M 52.12M 2025-12
Avita Medical AUD 62.68M 77K 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Moderna USD 2.4B 408M 2026-03
Organon & Co USD 2.39B 289M 2025-12
Pharma Mar EUR 93.88M 4.94M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12